Charrier, Marine
Lorant, Judith
Contreras-Lopez, Rafael
Téjédor, Gautier
Blanquart, Christophe
Lieubeau, Blandine
Schleder, Cindy
Leroux, Isabelle
Deshayes, Sophie
Fonteneau, Jean-François
Babarit, Candice
Hamel, Antoine
Magot, Armelle
Péréon, Yann
Viau, Sabrina
Delorme, Bruno
Luz-Crawford, Patricia
Lamirault, Guillaume
Djouad, Farida
Rouger, Karl
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-10-IBHU-005)
FEDER (FEDER, N°38436, N°PL0003686)
Article History
Received: 26 March 2021
Accepted: 9 December 2021
First Online: 10 January 2022
Declarations
:
: Human skeletal muscle tissue: Human MuStem cells were isolated from <i>Paravertebralis</i> muscle biopsies collected from patients aged 12–19 years. Patients were free of known muscle disease and had undergone surgery for acute scoliosis at the Department of Pediatric surgery of the Centre Hospitalier Universitaire (CHU) de Nantes (France). Written informed consent was obtained from all patients. All protocols were approved by the Clinical Research Department of the CHU (Nantes, France), according to the rules of the French Regulatory Health Authorities (approval number: MESR/DC-2010-1199). The biological sample bank was created in compliance with national guidelines regarding the use of human tissue for research (approval number: CPP/29/10). Isolation and culture of human bone marrow-derived mesenchymal stem cells: Human BM-MSCs were collected from patients undergoing hip replacement surgery. The patients were informed and provided written informed consent prior to collection of tissue samples as approved by the French Ministry of Higher Education and Research (DC-2010–1185).
: Not applicable.
: The authors declare that they have no financial and non-financial competing interests.